Executive Summary
On January 22, 2026, the USA S&P 500 Healthcare intelligence stream revealed sparse sector-specific activity amid a dominant wave of 34 8-K filings, with only 5 directly from healthcare firms (Abbott Labs, Intuitive Surgical, Revelation Biosciences, MBX Biosciences, Ventyx Biosciences) focused on routine earnings releases and officer changes, all neutral sentiment and low materiality. The filings were overwhelmed by ~80% non-healthcare financial institutions (regional banks like CVB Financial, Heritage Financial, Capital One) reporting Q4 earnings en masse, suggesting a broader market reporting confluence potentially diluting healthcare focus but signaling stable disclosure environment without disruptions. Cumulative impact points to low volatility in healthcare, with no systemic risks but limited alpha catalysts due to absent quantitative details.
Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from January 20, 2026.
Investment Signals(4)
- Abbott Laboratories (ABT)↓(BULLISH)▲
Routine Item 2.02 earnings release with low risk, potential for steady performance in diagnostics/devices amid neutral sector
- Intuitive Surgical (ISRG)(BULLISH)▲
Financial results disclosure under Item 2.02, consistent with sector stability and low risk profile
- MBX Biosciences↓(BULLISH)▲
Officer appointment/election under Item 5.02 could signal strengthened leadership for pipeline advancement
- Ventyx Biosciences↓(BULLISH)▲
Item 5.02 officer change with low risk, opportunity for fresh perspectives in biotech development
Risk Flags(3)
- Revelation Biosciences/Unknown Event↓[MEDIUM RISK]▼
Medium risk Item 8.01 disclosure with no details, potential undisclosed clinical/regulatory issues
- Bayview Acquisition/Delisting↓[HIGH RISK]▼
High risk notice of delisting (Item 3.01) tied to merger, spillover M&A caution for healthcare SPACs/biotech deals
- Multiple Biotechs/Officer Changes[MEDIUM RISK]▼
MBX, Ventyx, Digital Ally Item 5.02 filings lack departure reasons, possible talent flight amid biotech funding pressures
Opportunities(3)
- ◆
Neutral earnings 8-K offers entry for long-term holders if full review shows guidance stability in pharma/devices
Item 2.02 disclosure in robotics leader, potential undervaluation if procedures growth implied
- Biotech Officer Transitions(ALPHA)◆
MBX/Ventyx leadership changes could catalyze pipeline updates or partnerships in immunology/endocrinology
Sector Themes(3)
- Healthcare Earnings Stability◆
Limited but routine Item 2.02 filings from ABT/ISRG indicate steady disclosure cadence, low volatility for S&P 500 healthcare portfolios vs. financials surge
- Biotech Leadership Flux◆
Officer changes (Item 5.02) in Revelation/MBX/Ventyx signal potential talent realignment amid neutral sentiment, watch for innovation acceleration
- Cross-Sector Reporting Overlap◆
Financials' earnings flood (CVB, Capital One et al.) correlates with healthcare quiet, implying neutral macro funding environment for providers/biotechs
Watch List(4)
Unspecified Item 8.01 event, monitor for clinical trial or partnership reveals
Delisting/merger progression, implications for healthcare M&A liquidity
- Capital One (multiple filings)👁
Frequent 8-Ks including equity sales, track for credit conditions impacting healthcare financing
Full earnings exhibits for guidance, potential sector bellwethers
Filing Analyses(34)
22-01-2026
CVB Financial Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018599, Size: 13 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary.
22-01-2026
CVB Financial Corp filed an 8-K on January 22, 2026 (AccNo: 0001193125-26-018584, size 3 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a routine earnings announcement. No specific financial metrics, transaction values, or other quantitative data are provided in the filing summary.
22-01-2026
News Corp filed an 8-K on January 22, 2026 (AccNo: 0001564708-26-000015, Size: 414 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
22-01-2026
Revelation Biosciences, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018332, Size: 18 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed. Sector not specified.
22-01-2026
Amalgamated Financial Corp. filed a Form 8-K on January 22, 2026 (AccNo: 0001823608-26-000006, Size: 9 MB), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific quantitative metrics, transaction values, or detailed financial data provided in the summary. Sector is not specified.
22-01-2026
Abbott Laboratories filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-002982, Size: 952 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement from the US market. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
22-01-2026
MBX Biosciences, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018700, Size: 237 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
22-01-2026
Kearny Financial Corp. filed an 8-K on January 22, 2026 (AccNo: 0001617242-26-000002, Size: 4 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results in the US equity market. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
22-01-2026
Esquire Financial Holdings, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005642, size 4 MB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement. No specific financial metrics, transaction values, or quantitative data are mentioned in the filing summary.
22-01-2026
Norwood Financial Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-018738, Size: 7 MB), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned in the provided filing summary.
22-01-2026
Digital Ally, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003195, Size: 246 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason, or compensation provided.
22-01-2026
CITIZENS FINANCIAL GROUP INC/RI filed an 8-K on January 22, 2026 (AccNo: 0000759944-26-000020, Size: 5 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
22-01-2026
Bayview Acquisition Corp filed an 8-K on January 22, 2026 (AccNo: 0001493152-26-003194, Size: 327 KB), disclosing under Item 1.01 entry into a material definitive agreement related to a Merger/Acquisition event. Item 3.01 reports notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing. Item 9.01 provides financial statements and exhibits; no deal structure, parties, valuation, or financial metrics are specified.
22-01-2026
HERITAGE FINANCIAL CORP /WA/ filed a Form 8-K on January 22, 2026 (AccNo: 0001628280-26-003011, Size: 167 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, matters submitted, or exhibits are disclosed in the provided summary. This is a multi-item, mandatory disclosure typical of post-shareholder meeting filings.
22-01-2026
ENB Financial Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001174947-26-000070, Size: 234 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific metrics, amounts, or details are provided in the summary. Sector is not specified.
22-01-2026
ENB Financial Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001174947-26-000068, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no specific details on the event, transaction, or exhibits provided. All financial metrics, transaction values, and core event descriptions are NOT_DISCLOSED.
22-01-2026
HERITAGE FINANCIAL CORP /WA/ filed a Form 8-K on 2026-01-22 (AccNo: 0001628280-26-003035, size: 10 MB) reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.
22-01-2026
PATHWARD FINANCIAL, INC. filed a Form 8-K on January 22, 2026 (AccNo: 0000907471-26-000009, Size: 7 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction details, or quantitative data are mentioned in the provided filing summary.
22-01-2026
USCB FINANCIAL HOLDINGS, INC. filed an 8-K on January 22, 2026 (AccNo: 0001562762-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results with no specific numerical data, transaction details, or further content provided.
22-01-2026
Principal Financial Group Inc filed a Form 8-K on January 22, 2026, reporting under Item 7.01 Regulation FD Disclosure. Accession Number: 0001104659-26-005778, file size 192 KB. No specific details, transactions, financial metrics, or content of the disclosure are provided.
22-01-2026
Burke & Herbert Financial Services Corp. filed a Form 8-K on January 22, 2026 (AccNo: 0001964333-26-000005, Size: 4 MB), reporting Results of Operations and Financial Condition (Item 2.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing focused on financial results. No specific financial metrics, transaction values, or quantitative details are disclosed in the provided filing summary.
22-01-2026
CITIZENS & NORTHERN CORP filed a Form 8-K on January 22, 2026 (AccNo: 0001104659-26-005795), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data, named entities, and other specifics are NOT_DISCLOSED.
22-01-2026
Associated Banc-Corp filed an 8-K on January 22, 2026 (AccNo: 0000007789-26-000013, Size: 7 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure. No specific financial metrics, transaction values, or quantitative data are mentioned in the filing summary.
22-01-2026
Ventyx Biosciences, Inc. disclosed an Officer Change event via SEC Form 8-K filed on 2026-01-22 (AccNo: 0001193125-26-019453, Size: 175 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector not specified.
22-01-2026
Capital One Financial Corp filed an 8-K on January 22, 2026 (AccNo: 0001193125-26-019444, Size: 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific numerical data, transaction details, or other metrics provided in the filing summary. Sector is not specified.
22-01-2026
First Western Financial Inc filed an 8-K on January 22, 2026 (AccNo: 0001628280-26-003081, size 4 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.
22-01-2026
CAPITAL ONE FINANCIAL CORP filed a Form 8-K on January 22, 2026 (AccNo: 0000927628-26-000004, Size: 263 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific core event, transaction details, financial metrics, or named entities disclosed in the provided filing summary. Sector is not specified.
22-01-2026
THUMZUP MEDIA Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001493152-26-003250, Size: 622 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the provided filing summary. Sector not specified.
22-01-2026
South Plains Financial, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0001140361-26-002059, Size: 223 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
22-01-2026
Glacier Bancorp, Inc. filed a Form 8-K on January 22, 2026 (AccNo: 0000868671-26-000003, Size: 1 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard financial results announcement with no specific numerical financial metrics, transaction details, or other quantitative data provided in the filing summary. Sector is not specified.
22-01-2026
Bank of New York Mellon Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001193125-26-019554, Size: 246 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.
22-01-2026
Capital One Financial Corp filed an 8-K on January 22, 2026 (AccNo: 0001193125-26-019543, Size: 252 KB), reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, share counts, financial metrics, or other quantitative details disclosed in the provided summary. Analysis is limited to the reported items; core event details such as dollar value, strategic importance, or financial impacts are NOT_DISCLOSED.
22-01-2026
Intuitive Surgical Inc filed a Form 8-K on January 22, 2026 (AccNo: 0001035267-26-000006, Size: 444 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction details, or scheduled events are mentioned.
22-01-2026
OceanFirst Financial Corp filed a Form 8-K on January 22, 2026 (AccNo: 0001004702-26-000005, Size: 5 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific financial metrics, transaction details, or scheduled events are disclosed.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 34 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC